Sever Pharma Solutions
Kenneth Stokholm serves as the President and CEO of Sever Pharma Solutions since June 2019, overseeing an international pharmaceutical CDMO group with operations in Sweden, The Netherlands, and the US. Previous roles include Chairman of the Board at Disphar International BV, board member at Nordic Drugs, and various senior executive positions at Nordic Pharma where responsibilities encompassed technical operations, strategic development, and corporate business development. Stokholm's extensive experience also includes leadership roles at QPharma AB and Xellia Pharmaceuticals, where expertise in supply chain, operations, and production management was demonstrated. Educational qualifications encompass an Executive MBA from HEC Paris, a Mini MBA from CBS Executive Fonden, and an M.Sc. in Biotechnology from DTU - Technical University of Denmark.
This person is not in any offices
Sever Pharma Solutions
Sever Pharma Solutions brings your pharmaceutical ideas to life by offering expertise in high potent drug development, a drive to enhance performance, a passion for perfection, and a commitment to be your partner through the whole journey. We add value through the entire development and manufacturing processes with in-depth analytics, expertise in high potent drugs and polymer-based drug delivery systems, comprehensive material options, and creative solutions. By providing a complete value chain, from development to sourcing and worldwide commercial supply, we can offer you an optimized end-to-end solution. And as a committed long-term partner with a strong focus on creating a commercial product, we put all our resources at work for you to the finishing line – and beyond. Together with our global GMP compliance, regulatory services, and market access strategies, we can secure that your products will benefit patients all over the world.